BBI Brickell Biotech Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: BBI

Price (delayed)

$0.87

Market cap

$58.23M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.85

Enterprise value

$28.55M

Sector: Healthcare
Industry: Biotechnology
Website: https://brickellbio.com/

Highlights

Brickell Biotech's EPS has soared by 81% YoY and by 76% from the previous quarter
The quick ratio has soared by 77% from the previous quarter
BBI's gross profit has shrunk by 77% YoY and by 26% QoQ
The company's revenue has shrunk by 77% YoY and by 26% QoQ

Key stats

What are the main financial stats of BBI
Market
Shares outstanding
66.93M
Market cap
$58.23M
Enterprise value
$28.55M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.72
Price to sales (P/S)
11.71
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
15.67
Earnings
Revenue
$1.82M
EBIT
-$20.91M
EBITDA
-$20.9M
Free cash flow
-$20.06M
Per share
EPS
-$0.85
Free cash flow per share
-$0.82
Book value per share
$0.51
Revenue per share
$0.07
TBVPS
$1.37
Balance sheet
Total assets
$33.63M
Total liabilities
$6.5M
Debt
$437,000
Equity
$27.14M
Working capital
$27.18M
Liquidity
Debt to equity
0.02
Current ratio
5.28
Quick ratio
4.74
Net debt/EBITDA
1.42
Margins
EBITDA margin
-1,147.3%
Gross margin
100%
Net margin
-1,147.8%
Operating margin
-1,151.3%
Efficiency
Return on assets
-83.2%
Return on equity
-116.7%
Return on invested capital
N/A
Return on capital employed
-76.7%
Return on sales
-1,147.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

BBI stock price

How has the Brickell Biotech stock price performed over time
Intraday
3.57%
1 week
-10.31%
1 month
-31.5%
1 year
-27.5%
YTD
11.54%
QTD
-20.18%

Financial performance

How have Brickell Biotech's revenue and profit performed over time
Revenue
$1.82M
Gross profit
$1.82M
Operating income
-$20.98M
Net income
-$20.91M
Gross margin
100%
Net margin
-1,147.8%
BBI's gross profit has shrunk by 77% YoY and by 26% QoQ
The company's revenue has shrunk by 77% YoY and by 26% QoQ
The net margin has contracted by 16% from the previous quarter
BBI's operating margin is down by 16% from the previous quarter

Growth

What is Brickell Biotech's growth rate over time

Valuation

What is Brickell Biotech stock price valuation
P/E
N/A
P/B
1.72
P/S
11.71
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
15.67
Brickell Biotech's EPS has soared by 81% YoY and by 76% from the previous quarter
The price to book (P/B) is 108% higher than the 5-year quarterly average of 0.8 and 28% higher than the last 4 quarters average of 1.3
Brickell Biotech's equity has increased by 45% from the previous quarter
The company's revenue has shrunk by 77% YoY and by 26% QoQ
BBI's P/S is 74% higher than its last 4 quarters average of 6.5

Efficiency

How efficient is Brickell Biotech business performance
The ROE has plunged by 139% YoY but it has grown by 38% from the previous quarter
The company's return on assets has shrunk by 112% YoY but it rose by 28% QoQ
Brickell Biotech's ROS has decreased by 16% from the previous quarter

Dividends

What is BBI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for BBI.

Financial health

How did Brickell Biotech financials performed over time
Brickell Biotech's total assets has soared by 85% YoY and by 27% from the previous quarter
The quick ratio has soared by 77% from the previous quarter
The debt is 98% less than the equity
Brickell Biotech's debt to equity has soared by 100% YoY
Brickell Biotech's equity has increased by 45% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.